# Serina Therapeutics, Inc.: Form 8-K, filed Mar 7, 2024

- Company: [Serina Therapeutics, Inc.](/companies/ser.md) (CIK 1708599)
- Form: 8-K
- Filed: 2024-03-07
- Accepted by EDGAR: Mar 7, 2024, 16:47 ET
- Period: 2024-03-05
- Accession: 0001493152-24-009224
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1708599/000149315224009224/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1708599/000149315224009224/

## Items reported

- Item 2.03: New direct financial obligation
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1708599/000149315224009224/form8-k.htm

Filed Mar 7, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-009224. Last ingested by Listed: Nov 13, 2026, 15:52 ET. No prices; not investment advice.
